Medication Adherence, Family Support, and Cost-Effectiveness in Type 2 Diabetes Mellitus Management: A Narrative Review
DOI:
https://doi.org/10.35451/jfm.v9i1.3783Keywords:
Type 2 diabetes mellitus, Medication Adherence, Clinical Outcomes, Pharmaceutical Care, Pharmacist Intervention, TelepharmacyAbstract
Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease with a continuously increasing global prevalence. Successful T2DM management largely depends on patients' adherence to pharmacological therapy and overall disease management. However, medication adherence remains a major challenge, often resulting in failure to achieve glycemic targets, an increased risk of complications, and reduced quality of life. Pharmacists play a crucial role in improving medication adherence and clinical outcomes through various pharmaceutical care services, including pharmacist counseling, Medication Therapy Management (MTM), telepharmacy, home pharmacy care, and patient health education. Objective: This narrative review aimed to evaluate the impact of pharmaceutical care services on medication adherence and clinical outcomes among patients with T2DM based on published scientific evidence. Methods: A comprehensive electronic literature search was conducted using several international and national scientific databases, including PubMed, PubMed Central (PMC), Google Scholar, and ScienceDirect. A total of 50 eligible articles published between 2021 and 2026 were included in this review. Results: The findings demonstrated that pharmaceutical care services significantly improved medication adherence and clinical outcomes, as reflected by reductions in glycated hemoglobin (HbA1c), fasting blood International License. glucose (FBG), and random blood glucose (RBG) levels. Pharmaceutical care interventions combined with regular follow-up through telepharmacy or home pharmacy care were found to be more effective than conventional patient education alone. Conclusion: The evidence highlights that the active involvement of pharmacists is an essential component of T2DM management, contributing substantially to improved clinical outcomes and long-term therapeutic success.
Downloads
References
1. Devanbu, V. G. C., Porchezhian, P., John, J. B., & S, V. (2025). Effectiveness of Telemedicine and Electronic Call Reminder and Health Education Trial (TECARE Trial) for Type 2 Diabetes Mellitus: A Randomized Controlled Trial. Cureus, 17(9). https://doi.org/10.7759/cureus.91996
2. Kutluay, N. B., Bektay, M. Y., Sumbul-Sekerci, B., Sekerci, A., & Izzettin, F. V. (2025). Impact of clinical pharmacist integration on diabetes management: a prospective cohort. BMC Health Services Research, 25(1). https://doi.org/10.1186/s12913-025-12233-7
3. Wu, M., Xu, X., Zhao, R., Bai, X., Zhu, B., & Zhao, Z. (2023). Effect of Pharmacist-Led Interventions on Medication Adherence and Glycemic Control in Type 2 Diabetic Patients: A Study from the Chinese Population. Patient Preference and Adherence, 17 (January), 119–129. https://doi.org/10.2147/PPA.S394201
4. Soraya, I. A., Sauriasari, R., Prawiroharjo, P., & Risni, H. W. (2022). The Association between Adherence to Oral Antihyperglycemic Agent and HbA1c Level. 9(2), 93–101.
5. Eliza, D., Syafhan, N. F., Andrajati, R., & Fitriani, S. W. (2024). Pharmacist Monitoring Intervention via Telepharmacy on Clinical Outcomes and Quality of Life in patient with Type 2 Diabetes Mellitus: Pragmatic, Prospective Non-Randomized Controlled Trial. Research Journal of Pharmacy and Technology, 17(9), 4282–4290. https://doi.org/10.52711/0974-360X.2024.00662
6. Khan, Y. H., Alzarea, A. I., Alotaibi, N. H., Alatawi, A. D., Khokhar, A., Alanazi, A. S., Butt, M. H., Alshehri, A. A., Alshehri, S., Alatawi, Y., & Mallhi, T. H. (2022). Evaluation of Impact of a Pharmacist-Led Educational Campaign on Disease Knowledge, Practices and Medication Adherence for Type-2 Diabetic Patients: A Prospective Pre- and Post-Analysis. International Journal of Environmental Research and Public Health, 19(16). https://doi.org/10.3390/ijerph191610060
7. Besemah, N. A., Sartika, R. A. D., & Sauriasari, R. (2021). Effect of Pharmacist Intervention on Medication Adherence and Clinical Outcomes of Type 2 Diabetes Mellitus Outpatients in Primary Healthcare in Indonesia. Journal of Research in Pharmacy Practice, 9(4), 186–195. https://doi.org/10.4103/jrpp.JRPP_20_59
8. Ihekoronye, M. R., Osemene, K. P., & Oamen, T. E. (2024). Pharmacist-led intervention to improve treatment outcomes in type 2 diabetes: a randomized controlled trial. Journal of Pharmaceutical Health Services Research, 15(2). https://doi.org/10.1093/jphsr/rmae005
9. Khairunnisa, Rawitri, K., Wiryanto, & Wahyuni, S. (2021). Pengaruh Asuhan Kefarmasian Terhadap Outcome Klinis Dan Kualitas Hidup Pada Pasien Diabetes Melitus Tipe 2. JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X, 13(2), 118–128. https://doi.org/10.35617/jfionline.v13i2.18
10. Wang, W., Geng, L., Sun, C., Li, H., & Wang, J. (2022). Efficacy of Pharmaceutical Care in Patients with Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial. International Journal of Clinical Practice, 2022, 7681404. https://doi.org/10.1155/2022/7681404
11. Purwantiningsih, D., Yasin, N. M., & Kristina, S. A. (2021). Pengaruh Medication Therapy Management Terhadap Kepatuhan, Outcome Klinik dan Kualitas Hidup Pasien Diabetes Mellitus. Majalah Farmaseutik, 17(3), 391–397. https://doi.org/10.22146/farmaseutik.v1i1.62497
12. Saswita, N., Aditama, L., & Lorensia, A. (2023). Pengaruh Telefarmasi Terhadap Kepatuhan dan Target Pengobatan Pasien DMT2. MPI (Media Pharmaceutica Indonesiana), 5(2), 124–133. https://doi.org/10.24123/mpi.v5i2.5479
13. Wungrath, J., & Autorn, N. (2021). Effectiveness of line application and telephone-based counseling to improve medication adherence: A randomized control trial study among uncontrolled type 2 diabetes patients. Health Promotion Perspectives, 11(4), 438–443. https://doi.org/10.34172/hpp.2021.55
14. Fatiha, C. N., & Sabiti, F. B. (2021). Peningkatan Kepatuhan Minum Obat Melalui Konseling Apoteker pada Pasien Diabetes Mellitus Tipe 2 di Puskesmas Halmahera Kota Semarang. JPSCR: Journal of Pharmaceutical Science and Clinical Research, 6(1), 41. https://doi.org/10.20961/jpscr.v6i1.39297
15. Abubakar, M., & Atif, M. (2021). Impact of Pharmacist-Led Interventions on Diabetes Management at a Community Pharmacy in Pakistan: A Randomized Controlled Trial. Inquiry (United States), 58, 1–10. https://doi.org/10.1177/00469580211036283
16. Ilham Novalisa Aji Wibowo, M., Melisa Fitri, F., Munif Yasin, N., Ari Kristina, S., Suryo Prabandari, Y., Kesehatan Masyarakat, D., Kedokteran, F., Masyarakat, K., & Keperawatan, dan. (2021). Medication Adherence in Patients with Type 2 Diabetes in Several Health Centers of Banyumas District. JURNAL Kefarmasian Indonesia, 11(2), 98–108. https://doi.org./10.22
17. Saputri, P., Yasin, N. M., Kristina, S. A., Magister, M., Klinik, F., Farmasi, F., Mada, U. G., Farmakologi, D., Farmasi, F., Mada, U. G., Farmasetika, D., Farmasi, F., & Mada, U. G. (2026). Pengaruh Intervensi Apoteker Berbasis Medication Therapy Management Terhadap Luaran Klinis Pasien Lanjut Usia dengan Diabetes Melitus. 22(1), 68–76. https://doi.org/10.22146/farmaseutik.v22i1.104932
18. Rahmawati Raharjo, A. D. R. (2021). Wiraraja Medika : Jurnal Kesehatan. Wiraraja Medika: Jurnal Kesehatan, 10(1), 1–9.
19. Padmasari, S., Azizah, F. N., & Larasati, N. (2021). Edukasi Home Pharmacy Care terhadap Kepatuhan dan Kontrol Glukosa Darah pada Pasien Diabetes Melitus. Jurnal Sains Farmasi & Klinis, 8(2), 182. https://doi.org/10.25077/jsfk.8.2.182-189.2021
20. American Diabetes Association. (2025). Standards of Care in Diabetes—2025. Diabetes Care, 48(Suppl. 1).
21. Perkumpulan Endokrinologi Indonesia. (2024). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2024. PB PERKENI.
22. Badi, S., Suliman, S. Z., Almahdi, R., Aldomah, M. A., Marzouq, M. El., Ibrahim, E. E. M., Ahmed, M., Ahmed, M. H., Elkheir, H. K., & Ibrahim, M. I. M. (2024). The Impact of Clinical Pharmacist Diabetes Education on Medication Adherence in Patients with Type 2 Diabetes Mellitus: An Interventional Study from Khartoum, Sudan. Journal of Personalized Medicine, 14(1). https://doi.org/10.3390/jpm14010074
23. Alfian, R., Nita, Y., & Athiyah, U. (2025). Evaluation of Pharmacist-Based Services for Type 2 Diabetes Mellitus in the Indonesian Community Health Centers. Journal of Public Health and Pharmacy, 5(1), 1–10. https://doi.org/10.56338/jphp.v5i1.5888
24. Amin Abdullah, A., Catur Yuliani, F., Studi Ilmu Keperawatan, P., & Ilmu Kesehatan, F. (2025). Pengaruh Edukasi Kesehatan Terhadap Kepatuhan Minum Obat Pada Pasien Diabetes Melitus Tipe Ii Rawat Jalan Di Rumah Sakit Islam Sultan Hadlirin Jepara. Jurnal Multidisiplin Ilmu Akademik, 2(5), 194–199. https://doi.org/10.61722/jmia.v2i5.6506
25. Syifannisa, R., Muthoharoh, A., Ningrum, W. A., & Rahmatullah, S. (2022). Konseling Apoteker Meningkatkan Kepatuhan Pengobatan dan Menurunkan Kadar Gula Darah Pasien DM Tipe 2. Jurnal Ilmiah Kesehatan, 15(2), 93–102.
26. Sihombing, Y. R., Nasution, A., & Harun, R. R. (2018). Economic impact of counseling on the management of patients with type 2 diabetes mellitus admitted to a hospital. Asian Journal of Pharmaceutical and Clinical Research, 11(Special Issue 1), 94–96. https://doi.org/10.22159/ajpcr.2018.v11s1.26577
27. Nguyen, T. N. P., Thi, C. N., Phuong, T. P. T., Ngoc, Q. N., & Pham, H. T. (2025). Counseling Preferences Among Patients With Type 2 Diabetes: Implications for Personalized Care. Journal of Diabetes Research, 2025(1). https://doi.org/10.1155/jdr/9970845
28. RAHAYU, Yayuk Suyudi; ANGGRAENI, Ratih; TANJUNG, Nurhaliza. Evaluation of Antidiabetic Usage in Type Ii Dm Patients At Public Health Centre of Sei Kepayang Barat Asahan District. Jurnal Farmasimed (Jfm), 2022, 5.1: 87-91.
29. MEIRITA, Efilia; SARI, Anita. Evaluation of antibiotics usage rationality on diabetes mellitus type II patients at inpatient installation of Grandmed Hospital Lubuk Pakam in 2022. JURNAL FARMASIMED (JFM), 2022, 5.1: 73-79.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Vintha Sari Uly, Diana Laila Ramatillah, Kashif Ullah Khan
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright in each article is the property of the Author.
